Private Advisor Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.9K | Hold |
|
|||||
|
2025
Q1 | $28K | Hold |
|
|||||
|
2024
Q4 | $45.3K | Sell |
|
|||||
|
2024
Q3 | $61.6K | Hold |
|
|||||
|
2024
Q2 | $63.7K | Sell |
|
|||||
|
2024
Q1 | $151K | Sell |
|
|||||
|
2023
Q4 | $113K | Hold |
|
|||||
|
2023
Q3 | $94.4K | Hold |
|
|||||
|
2023
Q2 | $126K | Hold |
|
|||||
|
2023
Q1 | $111K | Sell |
|
|||||
|
2022
Q4 | $62.8K | Hold |
|
|||||
|
2022
Q3 | $121K | Sell |
|
|||||
|
2022
Q2 | $155K | Hold |
|
|||||
|
2022
Q1 | $224K | Hold |
|
|||||
|
2021
Q4 | $365K | Sell |
|
|||||
|
2021
Q3 | $634K | Buy |
|
|||||
|
2021
Q2 | $533K | Sell |
|
|||||
|
2021
Q1 | $658K | Sell |
|
|||||
|
2020
Q4 | $571K | Sell |
|
|||||
|
2020
Q3 | $815K | Sell |
|
|||||
|
2020
Q2 | $1.11M | Sell |
|
|||||
|
2020
Q1 | $1.08M | Sell |
|
|||||
|
2019
Q4 | $1.18M | Sell |
|
|||||
|
2019
Q3 | $991K | Sell |
|
|||||
|
2019
Q2 | $1.65M | Sell |
|
|||||
|
2019
Q1 | $2.34M | Sell |
|
|||||
|
2018
Q4 | $2.46M | Buy |
|
|||||
|
2018
Q3 | $3.02M | Sell |
|
|||||
|
2018
Q2 | $3.84M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.19M | Hold |
|
|||||
|
2017
Q3 | $3.66M | Buy |
|
|||||
|
2017
Q2 | $1.64M | Sell |
|
|||||
|
2017
Q1 | $3.36M | Sell |
|
|||||
|
2016
Q4 | $2.36M | Buy |
|
|||||
|
2016
Q3 | $3.29M | Sell |
|
|||||
|
2016
Q2 | $2.23M | Buy |
|